Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
BBC News
Full text, translation and AI summary — after signing in
- The full article in your language
- AI summary and translation from the original
- The same account works in the Suviy app
Comments
Sign in to join the conversation. Sign in
No comments yet.